ChartMill assigns a Buy % Consensus number of 83% to REVB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-14 | Roth MKM | Maintains | Buy |
| 2022-02-17 | Roth Capital | Initiate | Buy |
7 analysts have analysed REVB and the average price target is 21.68 USD. This implies a price increase of 2190.02% is expected in the next year compared to the current price of 0.9465.
The consensus rating for REVELATION BIOSCIENCES INC (REVB) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.